canavalin A nonreactive c-fetoprotein in amniotic fluid samples from pregnancies with normal and abnormal fetuses. In 167 samples from pregnancies with a normal outcome and normal values for total a-fetoprotein concentration in amniotic fluid the percentage decreased from a median value of 27.4% in the 13th week to 8.5% in the 21st week of gestation, and a statistically significant (p < 0.00 1) average decrease of 1.7% per week was found from the 14th to the 19th week. A similar average decrease (2.2%) was found in 22 pregnancies from which two or more samples were obtained. The clinical significance of this decrease is discussed. Of 108 samples from patients with above-normal values for total a-fetoprotein and a normal outcome, seven had a total a-fetoprotein above recommended cut-off values, and only one of these had a low percentage of concanavalin A nonreactive a-fetoprotein.
in contrast, for all 27 samples from pregnancies with a severe fetal malformation this percentage was low, even in one case where the total ce-fetoprotein concentration was below the recommended cut-off value. 
Materials and Methods
All amniotic fluid samples obtained by amniocentesis in early pregnancy for any purpose were examined for degree and type of blood contamination. Samples with any blood contamination were excluded from this study.
"Rocket" immunoelectrophoresis was used to quantify the AFP (7, 8) . The samples were stored at -20 #{176}C; repeat assay after storage showed no change in AFP concentrations or con A reactivity.
The 95% reference interval for total AFP in amniotic fluid has been described earlier (9) . Amniotic fluids studied were grouped as follows: (a) 167 samples from pregnancies with a normal APP concentration (i.e., within the 95% reference interval) and a normal outcome of pregnancy.
(b) 45 samples from 22 pregnancies with a normal outcome, where two or more samples were obtained at different gestational ages. (c) 108 samples from pregnancies where APP was above the 95% reference interval, but with a normal outcome of pregnancy.
(d) 27 samples from pregnancies with severe fetal malformations.
Con A crossed-line affinity immunoelectrophoresis was performed as described elsewhere (4), but with one slight modification:
both the first-and second-dimension gels were molded between two glass plates (10) . This modification gave a day-to-day coefficient of variation of 5% or less. Electrophoresis in the first dimension took place in a gel containing free con A, 300 g per cm3 (Pharmacia Fine Chemicals).
We put 10 L into the wells, and they were electrophoresed at 5 V/cm until a bromphenol blue-stained albumin marker had migrated 3.8 cm (a little longer than 1 h). Four first-dimension gel slabs were then transferred to the lower end of a 20 X 10 cm glass plate with an upper gel containing specific rabbit anti-AFP antibody (3.75 zL per cm3; DAKO Immunoglobulins Ltd.). Between the con A gel and the antibody gel was molded an APP-containing gel 3 mm wide.
The second-dimension electrophoresis was run at 2.5 V/cm for at least 16 h. The plates were then dried, stained with Coomassie Brillant Blue, and the percentage of APP nonreactive with con A was determined by planimetry or by measuring the heights of the two peaks above the APP line precipitate (Figure 1 ).
Results
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Sygehus, DK-6400 In group a, the 167 samples with a normal concentration of total APP and a normal outcome of pregnancy, the percentage of con A nonreactive APP decreased from a median value of 27.4% in the 13th gestational week to 8.5% in the 21st week ( Figure 2 analysis of variance, p <0.001) average decrease of 1.7% per week was found from the 14th through the 19th week. Figure 3 shows the percentage of con A nonreactive AFP for the 22 cases (group b) from whom two or more samples of amniotic fluid were obtained during the pregnancy.
In all cases the outcome of pregnancy was normal. The amniocenteses were repeated for reasons other than suspicion of fetal malformation. The percentages declined with time in all cases, the average rate of decline for these cases being 2.2% per week.
For group c, the 108 specimens from pregnancies with a normal outcome but with a concentration of total APP above the 95% reference interval, the results are indicated in Figure  4 . A general decrease in the percentage during the observed period is again evident. In seven of these cases the total APP value (Table 1) exceeded the cut-off concentration proposed by the U.K. Collaborative Study, but in six the con A nonreactive fraction of AFP was well within the normal range (i.e., above the dashed line in Figure 4 ). This line (i.e., the lower 0.1% limit for normal samples) was calculated by parametric statistics from results for 275 samples, because these samples were found to be log-normal distributed in each week. We looked for a possible correlation between the total APP concentration and the con A nonreactive percentage for the 140 samples from normal pregnancies (including eight pairs of twins) collected in the 15th through the 16th gestational week, seeking any association between both of the two variables and gestational age. No statistically significant correlation was found (Spearman rank correlation analysis: p >0.05) ( Figure  5 ). Figure  4 also includes data from 27 pregnancies involving fetal neural tube defect or other fetal abnormality.
In all cases the total APP concentration was above normal (median 180, range 45-600 mg/L), but in five cases (Table 2) 
Discussion
It has been suggested (5) We found no correlation between total APP concentration and the percentage of con A nonreactive AFP. Thus the con A nonreactive fraction seems to be independent of total AFP concentration, at least in specimens from normal pregnancies.
In seven unaffected pregnancies the concentrations of total APP were so high that they seemed to be diagnostic of fetal malformations, and in three of these cases the pregnancy was terminated ( Table 1 ). The percentage of con A nonreactive APP was within the normal range (shown in Figure 4 ) in all these cases except one.
In samples from pregnancies involving a neural tube defect or other severe fetal malformation ( Figure 4 , Table 2 ) the percentage of con A nonreactive AFP was always low, even in samples with total APP concentration close to the proposed ciit-off values. In one case the APP concentration was actually As seen in Figure 4 , the clinical usefulness of the con A test seems maximal before the 19th gestational week, but it is still useful thereafter in eliminating nearly all false positives (Table   1) . After the 19th gestational week a low percentage of con A nonreactive APP is of no diagnostic significance, because the percentage of nonreactive APP can be low in normal pregnancies (see Figure 2) . Two major problems have to be considered in interpreting 
